These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 26661498)

  • 41. Pathogenic human monoclonal antibody against desmoglein 3.
    Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
    Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6-associated pemphigus vulgaris.
    Tong JC; Tan TW; Sinha AA; Ranganathan S
    BMC Bioinformatics; 2006 Dec; 7 Suppl 5(Suppl 5):S7. PubMed ID: 17254312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3.
    Nagel A; Lang A; Engel D; Podstawa E; Hunzelmann N; de Pita O; Borradori L; Uter W; Hertl M
    Clin Immunol; 2010 Mar; 134(3):320-30. PubMed ID: 20015693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.
    Tsunoda K; Ota T; Suzuki H; Ohyama M; Nagai T; Nishikawa T; Amagai M; Koyasu S
    Eur J Immunol; 2002 Mar; 32(3):627-33. PubMed ID: 11857336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies.
    Lakoš Jukić I; Mokos M; Marinović B
    Front Immunol; 2023; 14():1200992. PubMed ID: 37529044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals.
    Hertl M; Amagai M; Sundaram H; Stanley J; Ishii K; Katz SI
    J Invest Dermatol; 1998 Jan; 110(1):62-6. PubMed ID: 9424089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controversial role of antibodies against linear epitopes of desmoglein 3 in pemphigus vulgaris, as revealed by semiquantitative living cell immunofluorescence microscopy and in-cell ELISA.
    Lanza A; Perillo L; Landi C; Femiano F; Gombos F; Cirillo N
    Int J Immunopathol Pharmacol; 2010; 23(4):1047-55. PubMed ID: 21244754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T Regulatory Cell-Associated Tolerance Induction by High-Dose Immunoglobulins in an HLA-Transgenic Mouse Model of Pemphigus.
    Hudemann C; Hoffmann J; Schmidt E; Hertl M; Eming R
    Cells; 2023 May; 12(9):. PubMed ID: 37174740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice.
    Takahashi H; Kouno M; Nagao K; Wada N; Hata T; Nishimoto S; Iwakura Y; Yoshimura A; Yamada T; Kuwana M; Fujii H; Koyasu S; Amagai M
    J Clin Invest; 2011 Sep; 121(9):3677-88. PubMed ID: 21821914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.
    Luyet C; Schulze K; Sayar BS; Howald D; Müller EJ; Galichet A
    PLoS One; 2015; 10(3):e0119809. PubMed ID: 25748204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunological hotspots analyzed by docking simulations: evidence for a general mechanism in pemphigus vulgaris pathology and transformation.
    Tong JC; Sinha AA
    BMC Immunol; 2008 Jun; 9():30. PubMed ID: 18564435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
    Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
    Hashimoto T; Amagai M; Garrod DR; Nishikawa T
    Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus.
    Heupel WM; Müller T; Efthymiadis A; Schmidt E; Drenckhahn D; Waschke J
    J Biol Chem; 2009 Mar; 284(13):8589-95. PubMed ID: 19164289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Family study of monozygotic twins affected by pemphigus vulgaris.
    Salathiel AM; Brochado MJ; Kim O; Deghaide NH; Donadi EA; Roselino AM
    Hum Immunol; 2016 Jul; 77(7):600-4. PubMed ID: 27177496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of Autoreactive B Cell Subpopulations in Peripheral Blood of Autoimmune Patients With Pemphigus Vulgaris.
    Pollmann R; Walter E; Schmidt T; Waschke J; Hertl M; Möbs C; Eming R
    Front Immunol; 2019; 10():1375. PubMed ID: 31258541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
    Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
    Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation.
    Saito M; Stahley SN; Caughman CY; Mao X; Tucker DK; Payne AS; Amagai M; Kowalczyk AP
    PLoS One; 2012; 7(12):e50696. PubMed ID: 23226536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Amagai M; Nishikawa T
    J Invest Dermatol; 2004 May; 122(5):1145-53. PubMed ID: 15140217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.